Nektar Therapeutics (NKTR) Asset Utilization Ratio (2011 - 2026)

Nektar Therapeutics' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.11 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 65.78% year-over-year to 0.11; the TTM figure through Mar 2026 stood at 0.11 (down 65.78% YoY), while the FY2025 annual figure was 0.19, down 32.59% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.11, down from 0.19 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.32 in Q2 2025, with the low at 0.1 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.19 (2025), against an average of 0.2.
• The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio soared 73.79% in 2023, then slumped 65.78% in 2026.
• Nektar Therapeutics' Asset Utilization Ratio stood at 0.12 in 2022, then jumped by 73.79% to 0.21 in 2023, then soared by 50.0% to 0.32 in 2024, then plunged by 40.99% to 0.19 in 2025, then plunged by 43.85% to 0.11 in 2026.
• Business Quant data shows NKTR's Asset Utilization Ratio at 0.11 in Q1 2026, 0.19 in Q4 2025, and 0.25 in Q3 2025.